The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource.
×
TSP48910-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to rilpivirine TSA206271-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine TSA206315-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine TSA206363-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine TSA206415-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine TSA206470-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine TSA206521-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine TSA206574-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine TSA206629-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to rilpivirine TSA206683-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine TSA206725-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine TSA206767-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine TSA206814-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine TSA206857-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine TSA206909-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine TSF456005-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 10.0 µM for 24.0 h 1 subfactor(s) TSF456006-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 3.33 µM for 24.0 h 1 subfactor(s) TSF456007-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 1.11 µM for 24.0 h 1 subfactor(s) TSF456008-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.37 µM for 24.0 h 1 subfactor(s) TSF456009-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.125 µM for 24.0 h 1 subfactor(s) TSF456010-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.04 µM for 24.0 h 1 subfactor(s) TSF560938-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.74 µM for 24.0 h 1 subfactor(s) TSF560937-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 2.22 µM for 24.0 h 1 subfactor(s) TSF560939-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.25 µM for 24.0 h 1 subfactor(s) TSF560940-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.08 µM for 24.0 h 1 subfactor(s) TSF560941-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.03 µM for 24.0 h 1 subfactor(s) TSF560942-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.01 µM for 24.0 h 1 subfactor(s) TSF456308-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 10.0 µM for 24.0 h 1 subfactor(s) TSF456309-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 3.33 µM for 24.0 h 1 subfactor(s) TSF456310-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 1.11 µM for 24.0 h 1 subfactor(s) TSF456311-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.37 µM for 24.0 h 1 subfactor(s) TSF456312-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.125 µM for 24.0 h 1 subfactor(s) TSF456313-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.04 µM for 24.0 h 1 subfactor(s) TSF561268-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 2.22 µM for 24.0 h 1 subfactor(s) TSF561270-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.25 µM for 24.0 h 1 subfactor(s) TSF561269-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.74 µM for 24.0 h 1 subfactor(s) TSF561271-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.08 µM for 24.0 h 1 subfactor(s) TSF561272-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.03 µM for 24.0 h 1 subfactor(s) TSF561273-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.01 µM for 24.0 h 1 subfactor(s) TSF456619-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 3.33 µM for 24.0 h 1 subfactor(s) TSF456620-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 1.11 µM for 24.0 h 1 subfactor(s) TSF456618-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 10.0 µM for 24.0 h 1 subfactor(s) TSF456621-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.37 µM for 24.0 h 1 subfactor(s) TSF456622-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.125 µM for 24.0 h 1 subfactor(s) TSF456623-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.04 µM for 24.0 h 1 subfactor(s) TSF561606-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.08 µM for 24.0 h 1 subfactor(s) TSF561604-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.74 µM for 24.0 h 1 subfactor(s) TSF561603-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 2.22 µM for 24.0 h 1 subfactor(s) TSF561605-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.25 µM for 24.0 h 1 subfactor(s) TSF561607-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.03 µM for 24.0 h 1 subfactor(s) TSF561608-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.01 µM for 24.0 h 1 subfactor(s) TSF456937-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 10.0 µM for 24.0 h 1 subfactor(s) TSF456938-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 3.33 µM for 24.0 h 1 subfactor(s) TSF456939-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 1.11 µM for 24.0 h 1 subfactor(s) TSF456940-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 0.37 µM for 24.0 h 1 subfactor(s) TSF456941-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 0.125 µM for 24.0 h 1 subfactor(s) TSF456942-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 0.04 µM for 24.0 h 1 subfactor(s) TSF561939-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 2.22 µM for 24.0 h 1 subfactor(s) TSF561942-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 0.08 µM for 24.0 h 1 subfactor(s) TSF561940-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 0.74 µM for 24.0 h 1 subfactor(s) TSF561941-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 0.25 µM for 24.0 h 1 subfactor(s) TSF561943-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 0.03 µM for 24.0 h 1 subfactor(s) TSF457267-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 10.0 µM for 24.0 h 1 subfactor(s) TSF457268-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 3.33 µM for 24.0 h 1 subfactor(s) TSF457269-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 1.11 µM for 24.0 h 1 subfactor(s) TSF457270-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.37 µM for 24.0 h 1 subfactor(s) TSF457271-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.125 µM for 24.0 h 1 subfactor(s) TSF457272-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.04 µM for 24.0 h 1 subfactor(s) TSF562273-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.25 µM for 24.0 h 1 subfactor(s) TSF562271-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 2.22 µM for 24.0 h 1 subfactor(s) TSF562272-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.74 µM for 24.0 h 1 subfactor(s) TSF562276-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.01 µM for 24.0 h 1 subfactor(s) TSF562274-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.08 µM for 24.0 h 1 subfactor(s) TSF562275-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.03 µM for 24.0 h 1 subfactor(s) TSF457592-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 3.33 µM for 24.0 h 1 subfactor(s) TSF457591-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 10.0 µM for 24.0 h 1 subfactor(s) TSF457594-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.37 µM for 24.0 h 1 subfactor(s) TSF457593-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 1.11 µM for 24.0 h 1 subfactor(s) TSF457595-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.125 µM for 24.0 h 1 subfactor(s) TSF457596-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.04 µM for 24.0 h 1 subfactor(s) TSF562607-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 2.22 µM for 24.0 h 1 subfactor(s) TSF562610-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.08 µM for 24.0 h 1 subfactor(s) TSF562608-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.74 µM for 24.0 h 1 subfactor(s) TSF562609-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.25 µM for 24.0 h 1 subfactor(s) TSF562612-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.01 µM for 24.0 h 1 subfactor(s) TSF562611-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.03 µM for 24.0 h 1 subfactor(s) TSF457914-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 3.33 µM for 24.0 h 1 subfactor(s) TSF457913-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 10.0 µM for 24.0 h 1 subfactor(s) TSF457915-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 1.11 µM for 24.0 h 1 subfactor(s) TSF457916-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 0.37 µM for 24.0 h 1 subfactor(s) TSF457917-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 0.125 µM for 24.0 h 1 subfactor(s) TSF562944-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 0.01 µM for 24.0 h 1 subfactor(s) TSF562940-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 0.74 µM for 24.0 h 1 subfactor(s) TSF562939-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 2.22 µM for 24.0 h 1 subfactor(s) TSF562941-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 0.25 µM for 24.0 h 1 subfactor(s) TSF562942-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 0.08 µM for 24.0 h 1 subfactor(s) TSF562943-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 0.03 µM for 24.0 h 1 subfactor(s) TSF458230-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to rilpivirine 10.0 µM for 24.0 h 1 subfactor(s) TSF458231-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to rilpivirine 3.33 µM for 24.0 h 1 subfactor(s) TSF458232-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to rilpivirine 1.11 µM for 24.0 h 1 subfactor(s) TSF458233-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to rilpivirine 0.37 µM for 24.0 h 1 subfactor(s) TSF458234-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to rilpivirine 0.125 µM for 24.0 h 1 subfactor(s) TSF458235-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to rilpivirine 0.04 µM for 24.0 h 1 subfactor(s) TSF458558-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 0.37 µM for 24.0 h 1 subfactor(s) TSF458555-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 10.0 µM for 24.0 h 1 subfactor(s) TSF458560-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 0.04 µM for 24.0 h 1 subfactor(s) TSF458556-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 3.33 µM for 24.0 h 1 subfactor(s) TSF458557-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 1.11 µM for 24.0 h 1 subfactor(s) TSF458559-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 0.125 µM for 24.0 h 1 subfactor(s) TSF563270-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 0.74 µM for 24.0 h 1 subfactor(s) TSF563271-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 0.25 µM for 24.0 h 1 subfactor(s) TSF563269-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 2.22 µM for 24.0 h 1 subfactor(s) TSF563272-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 0.08 µM for 24.0 h 1 subfactor(s) TSF563273-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 0.03 µM for 24.0 h 1 subfactor(s) TSF458873-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 1.11 µM for 24.0 h 1 subfactor(s) TSF458871-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 10.0 µM for 24.0 h 1 subfactor(s) TSF458872-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 3.33 µM for 24.0 h 1 subfactor(s) TSF458876-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.04 µM for 24.0 h 1 subfactor(s) TSF458874-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.37 µM for 24.0 h 1 subfactor(s) TSF458875-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.125 µM for 24.0 h 1 subfactor(s) TSF563595-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 2.22 µM for 24.0 h 1 subfactor(s) TSF563596-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.74 µM for 24.0 h 1 subfactor(s) TSF563597-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.25 µM for 24.0 h 1 subfactor(s) TSF563598-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.08 µM for 24.0 h 1 subfactor(s) TSF563599-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.03 µM for 24.0 h 1 subfactor(s) TSF563600-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.01 µM for 24.0 h 1 subfactor(s) TSF459181-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 10.0 µM for 24.0 h 1 subfactor(s) TSF459183-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 1.11 µM for 24.0 h 1 subfactor(s) TSF459182-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 3.33 µM for 24.0 h 1 subfactor(s) TSF459184-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 0.37 µM for 24.0 h 1 subfactor(s) TSF459185-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 0.125 µM for 24.0 h 1 subfactor(s) TSF459186-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 0.04 µM for 24.0 h 1 subfactor(s) TSF563930-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 0.25 µM for 24.0 h 1 subfactor(s) TSF563928-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 2.22 µM for 24.0 h 1 subfactor(s) TSF563929-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 0.74 µM for 24.0 h 1 subfactor(s) TSF563931-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 0.08 µM for 24.0 h 1 subfactor(s) TSF563932-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 0.03 µM for 24.0 h 1 subfactor(s) TSF459493-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 1.11 µM for 24.0 h 1 subfactor(s) TSF459496-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.04 µM for 24.0 h 1 subfactor(s) TSF459491-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 10.0 µM for 24.0 h 1 subfactor(s) TSF459492-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 3.33 µM for 24.0 h 1 subfactor(s) TSF459494-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.37 µM for 24.0 h 1 subfactor(s) TSF459495-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.125 µM for 24.0 h 1 subfactor(s) TSF564260-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.08 µM for 24.0 h 1 subfactor(s) TSF564257-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 2.22 µM for 24.0 h 1 subfactor(s) TSF564258-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.74 µM for 24.0 h 1 subfactor(s) TSF564261-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.03 µM for 24.0 h 1 subfactor(s) TSF564259-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.25 µM for 24.0 h 1 subfactor(s) TSF564262-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.01 µM for 24.0 h 1 subfactor(s) TSF459796-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 3.33 µM for 24.0 h 1 subfactor(s) TSF459797-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 1.11 µM for 24.0 h 1 subfactor(s) TSF459795-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 10.0 µM for 24.0 h 1 subfactor(s) TSF459798-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.37 µM for 24.0 h 1 subfactor(s) TSF459799-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.125 µM for 24.0 h 1 subfactor(s) TSF459800-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.04 µM for 24.0 h 1 subfactor(s) TSF564591-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 2.22 µM for 24.0 h 1 subfactor(s) TSF564592-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.74 µM for 24.0 h 1 subfactor(s) TSF564593-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.25 µM for 24.0 h 1 subfactor(s) TSF564594-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.08 µM for 24.0 h 1 subfactor(s) TSF564595-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.03 µM for 24.0 h 1 subfactor(s) TSF564596-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.01 µM for 24.0 h 1 subfactor(s) TSF460121-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 10.0 µM for 24.0 h 1 subfactor(s) TSF460122-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 3.33 µM for 24.0 h 1 subfactor(s) TSF460123-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 1.11 µM for 24.0 h 1 subfactor(s) TSF460124-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.37 µM for 24.0 h 1 subfactor(s) TSF460125-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.125 µM for 24.0 h 1 subfactor(s) TSF460126-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.04 µM for 24.0 h 1 subfactor(s) TSF564921-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.74 µM for 24.0 h 1 subfactor(s) TSF564920-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 2.22 µM for 24.0 h 1 subfactor(s) TSF564922-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.25 µM for 24.0 h 1 subfactor(s) TSF564923-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.08 µM for 24.0 h 1 subfactor(s) TSF564924-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.03 µM for 24.0 h 1 subfactor(s) TSF564925-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.01 µM for 24.0 h 1 subfactor(s) TSS456014-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 10.0 µM for 24.0 h TSS456015-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 3.33 µM for 24.0 h TSS456016-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 1.11 µM for 24.0 h TSS456017-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.37 µM for 24.0 h TSS456018-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.125 µM for 24.0 h TSS456019-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.04 µM for 24.0 h TSS560948-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.74 µM for 24.0 h TSS560947-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 2.22 µM for 24.0 h TSS560949-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.25 µM for 24.0 h TSS560950-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.08 µM for 24.0 h TSS560951-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.03 µM for 24.0 h TSS560952-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to rilpivirine 0.01 µM for 24.0 h TSS456317-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 10.0 µM for 24.0 h TSS456318-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 3.33 µM for 24.0 h TSS456319-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 1.11 µM for 24.0 h TSS456320-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.37 µM for 24.0 h TSS456321-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.125 µM for 24.0 h TSS456322-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.04 µM for 24.0 h TSS561278-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 2.22 µM for 24.0 h TSS561280-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.25 µM for 24.0 h TSS561279-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.74 µM for 24.0 h TSS561281-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.08 µM for 24.0 h TSS561282-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.03 µM for 24.0 h TSS561283-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to rilpivirine 0.01 µM for 24.0 h TSS456628-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 3.33 µM for 24.0 h TSS456629-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 1.11 µM for 24.0 h TSS456627-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 10.0 µM for 24.0 h TSS456630-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.37 µM for 24.0 h TSS456631-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.125 µM for 24.0 h TSS456632-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.04 µM for 24.0 h TSS561616-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.08 µM for 24.0 h TSS561614-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.74 µM for 24.0 h TSS561613-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 2.22 µM for 24.0 h TSS561615-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.25 µM for 24.0 h TSS561617-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.03 µM for 24.0 h TSS561618-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to rilpivirine 0.01 µM for 24.0 h TSS456946-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 10.0 µM for 24.0 h TSS456947-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 3.33 µM for 24.0 h TSS456948-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 1.11 µM for 24.0 h TSS456949-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 0.37 µM for 24.0 h TSS456950-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 0.125 µM for 24.0 h TSS456951-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 0.04 µM for 24.0 h TSS561949-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 2.22 µM for 24.0 h TSS561952-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 0.08 µM for 24.0 h TSS561950-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 0.74 µM for 24.0 h TSS561951-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 0.25 µM for 24.0 h TSS561953-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to rilpivirine 0.03 µM for 24.0 h TSS457276-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 10.0 µM for 24.0 h TSS457277-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 3.33 µM for 24.0 h TSS457278-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 1.11 µM for 24.0 h TSS457279-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.37 µM for 24.0 h TSS457280-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.125 µM for 24.0 h TSS457281-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.04 µM for 24.0 h TSS562283-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.25 µM for 24.0 h TSS562281-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 2.22 µM for 24.0 h TSS562282-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.74 µM for 24.0 h TSS562286-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.01 µM for 24.0 h TSS562284-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.08 µM for 24.0 h TSS562285-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to rilpivirine 0.03 µM for 24.0 h TSS457601-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 3.33 µM for 24.0 h TSS457600-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 10.0 µM for 24.0 h TSS457603-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.37 µM for 24.0 h TSS457602-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 1.11 µM for 24.0 h TSS457604-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.125 µM for 24.0 h TSS457605-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.04 µM for 24.0 h TSS562617-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 2.22 µM for 24.0 h TSS562620-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.08 µM for 24.0 h TSS562618-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.74 µM for 24.0 h TSS562619-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.25 µM for 24.0 h TSS562622-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.01 µM for 24.0 h TSS562621-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to rilpivirine 0.03 µM for 24.0 h TSS457923-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 3.33 µM for 24.0 h TSS457922-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 10.0 µM for 24.0 h TSS457924-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 1.11 µM for 24.0 h TSS457925-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 0.37 µM for 24.0 h TSS457926-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 0.125 µM for 24.0 h TSS562954-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 0.01 µM for 24.0 h TSS562950-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 0.74 µM for 24.0 h TSS562949-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 2.22 µM for 24.0 h TSS562951-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 0.25 µM for 24.0 h TSS562952-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 0.08 µM for 24.0 h TSS562953-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HUVEC.A after exposure to rilpivirine 0.03 µM for 24.0 h TSS458239-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to rilpivirine 10.0 µM for 24.0 h TSS458240-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to rilpivirine 3.33 µM for 24.0 h TSS458241-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to rilpivirine 1.11 µM for 24.0 h TSS458242-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to rilpivirine 0.37 µM for 24.0 h TSS458243-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to rilpivirine 0.125 µM for 24.0 h TSS458244-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to rilpivirine 0.04 µM for 24.0 h TSS458567-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 0.37 µM for 24.0 h TSS458564-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 10.0 µM for 24.0 h TSS458569-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 0.04 µM for 24.0 h TSS458565-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 3.33 µM for 24.0 h TSS458566-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 1.11 µM for 24.0 h TSS458568-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 0.125 µM for 24.0 h TSS563280-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 0.74 µM for 24.0 h TSS563281-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 0.25 µM for 24.0 h TSS563279-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 2.22 µM for 24.0 h TSS563282-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 0.08 µM for 24.0 h TSS563283-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to rilpivirine 0.03 µM for 24.0 h TSS458882-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 1.11 µM for 24.0 h TSS458880-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 10.0 µM for 24.0 h TSS458881-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 3.33 µM for 24.0 h TSS458885-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.04 µM for 24.0 h TSS458883-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.37 µM for 24.0 h TSS458884-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.125 µM for 24.0 h TSS563605-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 2.22 µM for 24.0 h TSS563606-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.74 µM for 24.0 h TSS563607-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.25 µM for 24.0 h TSS563608-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.08 µM for 24.0 h TSS563609-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.03 µM for 24.0 h TSS563610-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to rilpivirine 0.01 µM for 24.0 h TSS459190-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 10.0 µM for 24.0 h TSS459192-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 1.11 µM for 24.0 h TSS459191-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 3.33 µM for 24.0 h TSS459193-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 0.37 µM for 24.0 h TSS459194-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 0.125 µM for 24.0 h TSS459195-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 0.04 µM for 24.0 h TSS563940-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 0.25 µM for 24.0 h TSS563938-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 2.22 µM for 24.0 h TSS563939-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 0.74 µM for 24.0 h TSS563941-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 0.08 µM for 24.0 h TSS563942-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to rilpivirine 0.03 µM for 24.0 h TSS459502-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 1.11 µM for 24.0 h TSS459505-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.04 µM for 24.0 h TSS459500-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 10.0 µM for 24.0 h TSS459501-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 3.33 µM for 24.0 h TSS459503-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.37 µM for 24.0 h TSS459504-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.125 µM for 24.0 h TSS564270-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.08 µM for 24.0 h TSS564267-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 2.22 µM for 24.0 h TSS564268-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.74 µM for 24.0 h TSS564271-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.03 µM for 24.0 h TSS564269-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.25 µM for 24.0 h TSS564272-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to rilpivirine 0.01 µM for 24.0 h TSS459805-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 3.33 µM for 24.0 h TSS459806-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 1.11 µM for 24.0 h TSS459804-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 10.0 µM for 24.0 h TSS459807-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.37 µM for 24.0 h TSS459808-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.125 µM for 24.0 h TSS459809-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.04 µM for 24.0 h TSS564601-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 2.22 µM for 24.0 h TSS564602-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.74 µM for 24.0 h TSS564603-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.25 µM for 24.0 h TSS564604-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.08 µM for 24.0 h TSS564605-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.03 µM for 24.0 h TSS564606-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to rilpivirine 0.01 µM for 24.0 h TSS460130-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 10.0 µM for 24.0 h TSS460131-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 3.33 µM for 24.0 h TSS460132-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 1.11 µM for 24.0 h TSS460133-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.37 µM for 24.0 h TSS460134-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.125 µM for 24.0 h TSS460135-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.04 µM for 24.0 h TSS564931-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.74 µM for 24.0 h TSS564930-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 2.22 µM for 24.0 h TSS564932-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.25 µM for 24.0 h TSS564933-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.08 µM for 24.0 h TSS564934-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.03 µM for 24.0 h TSS564935-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to rilpivirine 0.01 µM for 24.0 h
TSP48910 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to rilpivirine
Public
https://clue.io/data/CMap2020#LINCS2020
Experimental design
No experimental design provided
Results
No results provided